Back

Impact of diabetes on coronary plaque characteristics and major adverse cardiovascular events

11 December 2024 (09:30 - 17:45)
Organised by: Logo
Congress Presentation Part of: Poster session 1 Imaging of Coronary Artery Disease EACVI Premium Access EuroEcho-Imaging 2024 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Ernestas Dvinelis

University Hospital Santaros Klinikos, Vilnius (Lithuania)

83 More presentations in this session

Presentation thumbnail
Diabetes duration over the adult life course and associations with cardiac structure in later life
Miss L. Al Saikhan (Dammam, SA)
Abstract
Presentation thumbnail
Right ventricular dysfunction in ischemic vs nonischemic dilated cardiomyopathy
Doctor S. Saraiya (Vadodara, IN)
Abstract Slides
Presentation thumbnail
Echocardiography in monitoring the therapeutic effect of levothyroxine replacement therapy in subclinical hypothyroidism
Doctor M. Pandrc (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Catheter-directed thrombolysis of massive pulmonary embolism in high risk bleeding patients (local experience in kenya, single centre study)
Doctor A. Mohamed (Nairobi, KE)
Abstract Slides
Presentation thumbnail
Non-ischemic etiology is a better prognostic factor of reverse left ventricular remodeling in patients with heart failure reduced ejection fraction
Doctor H. Yoon (Gwangju, KR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1

The Event

Event poster

EuroEcho-Imaging 2024

11 December 2024 09:30 CET
You may be interested in
thumbnail
Congress Presentation
The presence of adverse atherosclerotic coronary plaque features is associated with diabetes
9 May 2021
thumbnail
Congress Presentation
Insights into the reporting of major adverse cardiovascular events in coronary artery disease trials
30 August 2024
thumbnail
Congress Presentation
Morphological plaque characteristics and clinical outcomes of acute coronary syndrome patients with a cancer history
28 August 2020
thumbnail
Congress Presentation
Impact of SGLT2 inhibitor on mortality and cardiovascular outcomes in patients with type 2 diabetes mellitus with left main or multivessel coronary artery disease
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources